To include your compound in the COVID-19 Resource Center, submit it here.

DSMB backs Athenex's Phase III breast cancer trial of Oraxol

Athenex Inc. (NASDAQ:ATNX) said an independent DSMB recommended continuation of the Phase III Oraxol 001 trial

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE